Oral evidence transcript
| Published on: | Tuesday 12 December 2017 |
|---|---|
| Date: | Tuesday 14 November 2017 |
| Meeting on: | Tuesday 14 November 2017 |
| Part of event segment: | Untitled |
| Document ID: | 156446 |
Committees
Work packages
-
Life Sciences and the Industrial Strategy
Tuesday 18 July 2017 - Tuesday 18 July 2017
Witnesses
-
Dr Mark Hammond, Co-founder, Deep Science Ventures, Dr John Bowler, Fund Manager and Global Sector Specialist with responsibility for the health care sector, Schroders PLC, Dr Peter Hughes, Healthcare Equity Analyst, AXA Framlington Biotech Fund and Dr Andrew Elder, Partner, Albion Capital